Literature DB >> 21707960

The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin.

David C Whiteman1, William J Pavan, Boris C Bastian.   

Abstract

Converging lines of evidence from varied scientific disciplines suggest that cutaneous melanomas comprise biologically distinct subtypes that arise through multiple causal pathways. Understanding the respective relationships of each subtype with etiologic factors such as UV radiation and constitutional factors is the first necessary step toward developing refined prevention strategies for the specific forms of melanoma. Furthermore, classifying this disease precisely into biologically distinct subtypes is the key to developing mechanism-based treatments, as highlighted by recent discoveries. In this review, we outline the historical developments that underpin our understanding of melanoma heterogeneity, and we do this from the perspectives of clinical presentation, histopathology, epidemiology, molecular genetics, and developmental biology. We integrate the evidence from these separate trajectories to catalog the emerging major categories of melanomas and conclude with important unanswered questions relating to the development of melanoma and its cells of origin.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2011        PMID: 21707960      PMCID: PMC3395885          DOI: 10.1111/j.1755-148X.2011.00880.x

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  151 in total

Review 1.  Glial versus melanocyte cell fate choice: Schwann cell precursors as a cellular origin of melanocytes.

Authors:  Igor Adameyko; Francois Lallemend
Journal:  Cell Mol Life Sci       Date:  2010-05-09       Impact factor: 9.261

2.  Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma.

Authors:  Vikas K Goel; Alexander J F Lazar; Carla L Warneke; Mark S Redston; Frank G Haluska
Journal:  J Invest Dermatol       Date:  2006-01       Impact factor: 8.551

3.  Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma.

Authors:  A van Elsas; S F Zerp; S van der Flier; K M Krüse; C Aarnoudse; N K Hayward; D J Ruiter; P I Schrier
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

4.  Melanocytic nevi in very young children: the role of phenotype, sun exposure, and sun protection.

Authors:  David C Whiteman; Robyn M Brown; David M Purdie; Maria-Celia Hughes
Journal:  J Am Acad Dermatol       Date:  2005-01       Impact factor: 11.527

5.  Naevi in schoolchildren in Scotland and Australia.

Authors:  L Fritschi; P McHenry; A Green; R Mackie; L Green; V Siskind
Journal:  Br J Dermatol       Date:  1994-05       Impact factor: 9.302

6.  NRG1 / ERBB3 signaling in melanocyte development and melanoma: inhibition of differentiation and promotion of proliferation.

Authors:  Kristina Buac; Mai Xu; Julie Cronin; Ashani T Weeraratna; Stephen M Hewitt; William J Pavan
Journal:  Pigment Cell Melanoma Res       Date:  2009-07-30       Impact factor: 4.693

7.  Latitude gradients in melanoma incidence and mortality in the non-Maori population of New Zealand.

Authors:  J L Bulliard; B Cox; J M Elwood
Journal:  Cancer Causes Control       Date:  1994-05       Impact factor: 2.506

8.  Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma.

Authors:  Nancy E Thomas; Sharon N Edmiston; Audrey Alexander; Robert C Millikan; Pamela A Groben; Honglin Hao; Dawn Tolbert; Marianne Berwick; Klaus Busam; Colin B Begg; Dianne Mattingly; David W Ollila; Chiu Kit Tse; Amanda Hummer; Julia Lee-Taylor; Kathleen Conway
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-05       Impact factor: 4.254

9.  Two distinct types of mouse melanocyte: differential signaling requirement for the maintenance of non-cutaneous and dermal versus epidermal melanocytes.

Authors:  Hitomi Aoki; Yasuhiro Yamada; Akira Hara; Takahiro Kunisada
Journal:  Development       Date:  2009-06-24       Impact factor: 6.868

10.  Incidence of malignant melanoma of the skin in England and Wales and its relationship to sunshine.

Authors:  A J Swerdlow
Journal:  Br Med J       Date:  1979-11-24
View more
  67 in total

1.  β-catenin in metastatic melanoma--the smoking gun reloaded.

Authors:  Terry Van Dyke; Glenn Merlino
Journal:  Pigment Cell Melanoma Res       Date:  2012-01-12       Impact factor: 4.693

2.  Classification of reticular pattern and streaks in dermoscopic images based on texture analysis.

Authors:  Marlene Machado; Jorge Pereira; Rui Fonseca-Pinto
Journal:  J Med Imaging (Bellingham)       Date:  2015-12-29

Review 3.  Current position of TNF-α in melanomagenesis.

Authors:  Iuliana Nenu; Diana Tudor; Adriana Gabriela Filip; Ioana Baldea
Journal:  Tumour Biol       Date:  2015-08-18

4.  A new KIT mutation (N505I) in acral melanoma confers constitutive signaling, favors tumorigenic properties, and is sensitive to imatinib.

Authors:  Maryline Allegra; Damien Giacchero; Coralie Segalen; Nicolas Dumaz; Catherine Butori; Véronique Hofman; Paul Hofman; Jean-Philippe Lacour; Corine Bertolotto; Philippe Bahadoran; Robert Ballotti
Journal:  J Invest Dermatol       Date:  2013-12-06       Impact factor: 8.551

5.  Role of TRPM in melanocytes and melanoma.

Authors:  Huazhang Guo; John Andrew Carlson; Andrzej Slominski
Journal:  Exp Dermatol       Date:  2012-09       Impact factor: 3.960

6.  Differential AKT dependency displayed by mouse models of BRAFV600E-initiated melanoma.

Authors:  Victoria Marsh Durban; Marian M Deuker; Marcus W Bosenberg; Wayne Phillips; Martin McMahon
Journal:  J Clin Invest       Date:  2013-11-08       Impact factor: 14.808

7.  Metastatic melanoma mimicking solitary fibrous tumor: report of two cases.

Authors:  Elise M Bekers; Adriana C H van Engen-van Grunsven; Patricia J T A Groenen; Harm Westdorp; Rutger H T Koornstra; Johannes J Bonenkamp; Uta Flucke; Willeke A M Blokx
Journal:  Virchows Arch       Date:  2014-01-24       Impact factor: 4.064

8.  Melanoma subtypes demonstrate distinct PD-L1 expression profiles.

Authors:  Genevieve J Kaunitz; Tricia R Cottrell; Mohammed Lilo; Valliammai Muthappan; Jessica Esandrio; Sneha Berry; Haiying Xu; Aleksandra Ogurtsova; Robert A Anders; Alexander H Fischer; Stefan Kraft; Meg R Gerstenblith; Cheryl L Thompson; Kord Honda; Jonathan D Cuda; Charles G Eberhart; James T Handa; Evan J Lipson; Janis M Taube
Journal:  Lab Invest       Date:  2017-07-24       Impact factor: 5.662

9.  Does an increased number of moles correlate to a higher risk of melanoma?

Authors:  Mehul Bhatt; Adam Nabatian; David Kriegel; Hooman Khorasani
Journal:  Melanoma Manag       Date:  2016-05-19

Review 10.  The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia.

Authors:  Boris C Bastian
Journal:  Annu Rev Pathol       Date:  2014       Impact factor: 23.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.